| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |